Day: March 22, 2021

HOUSTON, March 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Stabilis Solutions, Inc. (OTCQX: SLNG), a leading provider of distributed liquified natural gas “LNG” and hydrogen fuels, today announced that Jim Reddinger, President and Chief Executive Officer, and Andy Puhala, Senior Vice President and Chief Financial Officer, will be attending the Q1 Virtual Investor Summit. Following the event, a replay of the presentation will also be available in the investor center on the Stabilis website (www.stabilis-solutions.com). About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors. To...

ASHBURN, Va., March 22, 2021 (GLOBE NEWSWIRE) — The following release corrects and replaces the version that was sent out at 08:55 ET on March 17, 2021. The fourth paragraph has been replaced to reflect updated information. Telos®Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that Zscaler has selected Telos’ enterprise cyber risk management framework, Xacta®, for management and automation of FedRAMP and Department of Defense (DoD) authorizations. “Every organization is challenged to meet a maze of current and new compliance regulations and standards – particularly in the government community,” said Stephen R. Kovac, vice president of global government and head of corporate compliance, Zscaler. “We see these challenges...

TORONTO, March 22, 2021 (GLOBE NEWSWIRE) — O2Gold Inc. (“O2Gold” or the “Company”) (TSXV: OTGO) announces today that, further to its news releases dated January 15, 2021 and February 8, 2021, the TSX Venture Exchange (“TSXV”) has granted an extension of 30 days for filing final documentation in respect of the previously announced private placement (the “Offering”). The Company plans to issue up to 25,000,000 units (each, a “Unit”) at a price of $0.20 per Unit for gross proceeds of up to $5,000,000. Each Unit will consist of one common share of the Company (each, a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share at an exercise price of $0.30 for a period of 24 months from issuance. Closing of the Offering...

BOCA RATON, FL, March 22, 2021 (GLOBE NEWSWIRE) — NextGen Acquisition Corp. II (the “Company”) announced today that it priced its initial public offering of 35,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “NGCAU” beginning March 23, 2021. Each unit consists of one Class A ordinary share and one-fifth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on Nasdaq under the symbols “ NGCA” and “NGCAW,” respectively. The offering is expected to close on March 25, 2021, subject to...

— EXPAREL is the first and only FDA-approved long-acting local analgesic for children aged six and over –— Conference call tomorrow at 8:30 a.m. ET — PARSIPPANY, N.J., March 22, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the submission of its supplemental new drug application (sNDA) seeking expansion of the EXPAREL label to include use in patients 6 years of age and older for single-dose infiltration to produce postsurgical local analgesia. With this approval, EXPAREL is the first and only FDA approved long-acting local analgesic for the pediatric population as young as age six. “The current standard of care for managing...

NEW YORK, March 22, 2021 (GLOBE NEWSWIRE) — Newbury Street Acquisition Corporation (the “Company” or “NBST”) announced today that it priced its initial public offering of 12,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “NBSTU” beginning on March 23, 2021. Each unit consists of one share of common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, shares of the common stock and warrants are expected to be listed on Nasdaq under the symbols “NBST” and “NBSTW,” respectively. NBST is a special purpose...

MONACO, March 22, 2021 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced that Scorpio Holdings Limited, a related party, has purchased 40,000 common shares of the Company today in the open market at an average price of $19.56 per share. About Scorpio Tankers Inc. Scorpio Tankers is a provider of marine transportation of petroleum products worldwide. The Company’s fleet consists of 135 owned, finance leased or bareboat chartered-in product tankers (42 LR2 tankers, 12 LR1 tankers, 63 MR tankers and 18 Handymax tankers) with an average age of 5.3 years. Additional information about the Company is available at the Company’s website www.scorpiotankers.com, which is not a part of this press release. Forward-Looking Statements Matters discussed in this press release may constitute forward‐looking...

NEW HAVEN, Conn., March 22, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”) a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has applied for approval from the TSX Venture Exchange to extend the expiry date of 5,797,795 common share purchase warrants issued to subscribers pursuant to the private placement of units which closed on April 11, 2017 and to amend the exercise price of the warrants. Bioasis intends to extend the expiry date of the warrants from April 11, 2021 until April 11, 2022 and to...

MONTREAL, March 22, 2021 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced the commencement of a cash tender offer (the “Tender Offer”) to purchase for cash up to $1,100,000,000 aggregate purchase price (exclusive of accrued and unpaid interest) (as such aggregate purchase price may be increased or decreased by the Company, the “Aggregate Maximum Purchase Amount”) of its outstanding Notes of the three series listed in the table below (collectively, “Notes”); provided that the Company will only accept for purchase its 6.125% Senior Notes due 2023 having an aggregate purchase price of up to $250,000,000 (exclusive of accrued and unpaid interest) (as such aggregate purchase price for 2023 Notes may be increased or decreased by the Company, the “2023 Tender Cap”). The Tender Offer is being made pursuant to an Offer to...

MONTRÉAL, 22 mars 2021 (GLOBE NEWSWIRE) — Bombardier Inc. (« Bombardier » ou « Société ») a annoncé aujourd’hui le lancement d’une offre publique de rachat au comptant (« offre publique de rachat ») visant le rachat au comptant de ses billets en circulation des trois séries indiquées dans le tableau ci-dessous (collectivement, « billets ») jusqu’à concurrence d’un prix de rachat global de 1 100 000 000 $ (à l’exclusion des intérêts courus et impayés) (le prix de rachat global pouvant être augmenté ou diminué par la Société, « montant de rachat maximal global »); toutefois la Société n’acceptera, à des fins de rachat, que ses billets de premier rang 6,125 % échéant en 2023 ayant un prix de rachat global maximal de 250 000 000 $ (à l’exclusion des intérêts courus et impayés) (le prix de rachat global des billets de 2023 pouvant être...